Blog
RSS FeedPosted by Michael Wonder on 19 Feb 2018
August 2018 PBAC special meeting
19 February 2018 - Options for listing of pan-tumour indications for PDL-1 cancer immunotherapies on the PBS. ...
Posted by Michael Wonder on 18 Feb 2018
Win for cancer patients may be end to chemotherapy as immunotherapies fast-tracked
19 February 2018 - Chemotherapy could become a thing of the past for up to two in three cancer patients ...
Posted by Michael Wonder on 16 Feb 2018
Quebec and New Brunswick become first provinces to provide public funding of Ibrance for the first-line treatment of metastatic breast cancer
15 February 2018 - Since Ibrance received Health Canada marketing authorisation in March 2016, Canadian women living with metastatic breast cancer ...
Posted by Michael Wonder on 16 Feb 2018
Agenda for 21 February TC meeting
16 February 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 15 Feb 2018
Canadian patient groups call on Federal Health Minister to halt the process examining proposed amendments to the Patented Medicine Regulations pending constructive consultations
15 February 2018 - Patient feedback has not been considered – groups seek meaningful dialogue with Government and drug manufactures ...
Posted by Michael Wonder on 15 Feb 2018
Canadians are being fooled into thinking we'll like pharmacare. We really, really won't.
15 February 2018 - The idea that a government-run drug insurance monopoly will cost less and deliver the same benefits as ...
Posted by Michael Wonder on 15 Feb 2018
Alternative treatments for people with thyroid cancer to be offered routinely on the NHS, says NICE
15 February 2018 - The new guidance recommends three drugs, treating two types of thyroid cancer to be made routinely available ...
Posted by Michael Wonder on 13 Feb 2018
Almost 1 million Canadians give up food, heat to afford prescriptions: study
13 February 2018 - 968,000 people skimped on necessities to pay for their medicine in 2016, researchers find. ...
Posted by Michael Wonder on 13 Feb 2018
Plaque psoriasis patients to get NHS access to Leo’s Kyntheum
13 February 2018 - Patients with severe plaque psoriasis are a step closer to getting NHS funded access to Leo ...
Posted by Michael Wonder on 13 Feb 2018
More Australians dispose of health insurance because of rising premiums
14 February 2018 - More than 12,000 Australians ditched their hospital cover in the three months to last December, new ...
Posted by Michael Wonder on 13 Feb 2018
MA welcomes passing of PBS Amendment Bill
13 February 2018 - Medicines Australia welcomes the passing of the PBS National Health Amendment (Pharmaceutical Benefits – Budget and ...
Posted by Michael Wonder on 12 Feb 2018
Scots patients with advanced bladder cancer get first new drug for 25 years after SMC approves pembrolizumab
12 February 2018 - Bladder cancer patients whose tumours have spread are set to get a new drug on the ...
Posted by Michael Wonder on 12 Feb 2018
SMC - February 2018 decisions
12 February 2018 - Medicines for bladder cancer, skin cancer and multiple sclerosis among five new treatments accepted for use ...
Posted by Michael Wonder on 12 Feb 2018
Drug company says it will negotiate terms to allow children to access new treatment for rare genetic disorder
12 February 2018 - NICE has published draft guidance that does not recommend the drug cerliponase alfa (Brineura; Biomarin) for children ...
Posted by Michael Wonder on 12 Feb 2018
NICE backs EUSA’s kidney cancer drug Fotivda
12 February 2018 - NICE) has published draft guidelines backing use of EUSA Pharma’s Fotivda as a first-line treatment option ...